Literature DB >> 31271996

A translational concept of immuno-radiobiology.

Bodo E Lippitz1, Robert A Harris2.   

Abstract

BACKGROUND: Traditional concepts of radiobiology model the direct radiation-induced cellular cytotoxicity but are not focused on late and sustained effects of radiation. Recent experimental data show the close involvement of immunological processes.
METHODS: Based on systematic PubMed searches, experimental data on immunological radiation effects are summarized and analyzed in a non-quantitative descriptive manner to provide a translational perspective on the immuno-modulatory impact of radiation in cancer.
RESULTS: Novel experimental findings document that sustained radiation effects are ultimately mediated through systemic factors such as cytotoxic CD8+ T cells and involve a local immuno-stimulation. Increased tumor infiltration of CD8+ T cell is a prerequisite for long-term radiation effects. CD8+ T cell depletion induces radio-resistance in experimental tumors. The proposed sequence of events involves radiation-damaged cells that release HMGB1, which activates macrophages via TLR4 to a local immuno-stimulation via TNF, which contributes to maturation of DCs. The mature DCs migrate to lymph nodes where they trigger effective CD8+ T cell responses. Radiation effects are boosted, when the physiological self-terminating negative feedback of immune reactions is antagonised via blocking of TGF-β or via checkpoint inhibition with involvement of CD8+ T cells as common denominator.
CONCLUSION: The concept of immuno-radiobiology emphasizes the necessity for a functional integrity of APCs and T cells for the long-term effects of radiotherapy. Local irradiation at higher doses induces tumor infiltration of CD8+ T cells, which can be boosted by immunotherapy. More systematic research is warranted to better understand the immunological effects of escalating radiation doses.
Copyright © 2019 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CD8+ T cells; Immuno-radiobiology; Onco-immunology; Radiobiology; Radiosurgery; Radiotherapy

Mesh:

Year:  2019        PMID: 31271996     DOI: 10.1016/j.radonc.2019.06.001

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  6 in total

Review 1.  Uncovering sex differences of rodent microglia.

Authors:  Jinming Han; Yueshan Fan; Kai Zhou; Klas Blomgren; Robert A Harris
Journal:  J Neuroinflammation       Date:  2021-03-17       Impact factor: 8.322

2.  Ablative Radiotherapy Reprograms the Tumor Microenvironment of a Pancreatic Tumor in Favoring the Immune Checkpoint Blockade Therapy.

Authors:  Yu-Hung Lee; Ching-Fang Yu; Ying-Chieh Yang; Ji-Hong Hong; Chi-Shiun Chiang
Journal:  Int J Mol Sci       Date:  2021-02-19       Impact factor: 5.923

3.  Dynamic Characteristics and Predictive Capability of Tumor Voxel Dose-Response Assessed Using 18F-FDG PET/CT Imaging Feedback.

Authors:  Shupeng Chen; An Qin; Di Yan
Journal:  Front Oncol       Date:  2022-07-06       Impact factor: 5.738

4.  Pan-Cancer Analysis of Radiotherapy Benefits and Immune Infiltration in Multiple Human Cancers.

Authors:  Pengbo Wen; Yang Gao; Bin Chen; Xiaojing Qi; Guanshuo Hu; An Xu; Junfeng Xia; Lijun Wu; Huayi Lu; Guoping Zhao
Journal:  Cancers (Basel)       Date:  2020-04-13       Impact factor: 6.639

Review 5.  Trial Watch: experimental TLR7/TLR8 agonists for oncological indications.

Authors:  Giorgio Frega; Qi Wu; Julie Le Naour; Erika Vacchelli; Lorenzo Galluzzi; Guido Kroemer; Oliver Kepp
Journal:  Oncoimmunology       Date:  2020-07-21       Impact factor: 8.110

6.  Carbon Ion Radiotherapy Acts as the Optimal Treatment Strategy for Unresectable Liver Cancer During the Coronavirus Disease 2019 Crisis.

Authors:  Zheng Li; Qiang Li; Xiaohu Wang; Sha Li; Weiqiang Chen; Xiaodong Jin; Xinguo Liu; Zhongying Dai; Xiongxiong Liu; Xiaogang Zheng; Ping Li; Hui Zhang; Qiuning Zhang; Hongtao Luo; Ruifeng Liu
Journal:  Front Public Health       Date:  2021-12-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.